SCHEMBL8564687

SCHEMBL8564687

COC(=O)CCc1[nH]c(=O)n(-c2ccc3c(c2)CCN(C(=O)C(F)(F)F)CC3)c1C1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.38
ESR2 Q92731 3/20 0.38
TMEM97 Q5BJF2 2/20 0.32
SIGMAR1 Q99720 2/20 0.32
PDE4B Q07343 1/20 0.32
PDE4D Q08499 1/20 0.32
LMNA P02545 1/20 0.31
HDAC6 Q9UBN7 2/20 0.31
HRH3 Q9Y5N1 2/20 0.31
CHRM4 P08173 1/20 0.31
HTR1A P08908 1/20 0.31
CHRM5 P08912 1/20 0.31
ADRA2A P08913 1/20 0.31
ADRA2B P18089 1/20 0.31
HRH2 P25021 1/20 0.31
ADRA1D P25100 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
ADRA1A P35348 1/20 0.31
HRH1 P35367 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8565563 0.87 INSR (0.34) TMEM97SIGMAR1LMNAHRH3SMN1; SMN2
SCHEMBL8567149 0.82 ESR1 (0.38) ESR1ESR2TMEM97SIGMAR1PDE4B
SCHEMBL8563251 0.74 ESR1 (0.39) ESR1ESR2TMEM97SIGMAR1PDE4B
SCHEMBL8567196 0.74 ESR1 (0.39) ESR1ESR2TMEM97SIGMAR1PDE4B
SCHEMBL8559448 0.74 ESR1 (0.39) ESR1ESR2TMEM97SIGMAR1PDE4B
SCHEMBL8559207 0.73 MAPT (0.43) ESR1ESR2SMN1; SMN2
SCHEMBL8559199 0.73 ESR1 (0.39) ESR1ESR2PDE4BPDE4DBACE1
SCHEMBL8563245 0.73 ESR1 (0.38) ESR1ESR2TMEM97SIGMAR1PDE4B
SCHEMBL8567192 0.72 ESR1 (0.37) ESR1ESR2TMEM97SIGMAR1PDE4B
SCHEMBL8562057 0.71 ESR1 (0.38) ESR1ESR2TMEM97SIGMAR1PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5827849-A HAVING INHIBITORY EFFECT ON INFLAMMATION AND BONE DEGRADATION, ANTITHROMBOTIC, ANTIAGGREGATORY AND TUMOR- OR METASTASIS-INHIBITING EFFECT KARL THOMAE GMBH (DE) 1998-10-27 US disclosed